Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF).

Yasser Ged,Ruby Gupta,Cihan Duzgol,Natalie Shapnik,Almedina Redzematovic,Ritesh Kotecha,Martin H. Voss,Darren R. Feldman,Oguz Akin,Sujata Patil,Robert J. Motzer,Brian I. Rini,Chung-Han Lee

Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF).

2019

Yasser Ged
Ruby Gupta
Cihan Duzgol
Natalie Shapnik
Almedina Redzematovic
Ritesh Kotecha
Martin H. Voss
Darren R. Feldman
Oguz Akin
Sujata Patil
Robert J. Motzer
Brian I. Rini
Chung-Han Lee

4576Background: IO-VEGF combinations are the backbone for current and future therapeutic developments in RCC with several IO-VEGF regimens reporting positive results in phase 3 trials. However, lim...

Keywords:

Targeted therapy
VEGF receptors
Clear cell renal cell carcinoma
Immune system
Systemic therapy
Internal medicine
Medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations